REQUIP MODUTAB 2 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ROPINIROLE AS HYDROCHLORIDE 2 MG
Available from:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC code:
N04BC04
Pharmaceutical form:
FILM COATED TABLETS - PROLONGED RELEASE
Administration route:
PER OS
Manufactured by:
SMITHKLINE BEECHAM PLC, UK
Therapeutic group:
ROPINIROLE
Therapeutic indications:
Ropinirole is indicated for the treatment of Parkinson's disease. Ropinirole is effective as early therapy in patients requiring dopaminergic therapy. As adjunctive treatment to L-dopa, ropinirole enhances the efficacy of L-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic L-dopa therapy and permits reduction in daily L-dopa dose.
Authorization date:
2009-09-01
